Though not clearly established, it seems likely that different cancers can exploit this membrane-protective characteristic of IRE1α to become resistant to membrane damage caused by chemotherapy, immunotherapies, and high-dose radiation therapies. This evidence concerns the gene ERN1 and cancer.